Search research articles
Contact Us
Filters
Showing results (121-130 of 130) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 130 results.
ESMO Open
|
December 24, 2021
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities
M Simbolo, G Centonze, G Ali, et al.
Journal of Viral Hepatitis
|
August 9, 2017
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study
M Barone, A Iannone, E Shahini, et al.
ESMO Open
|
January 4, 2025
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)
M Reni, M Milella, F Bergamo, et al.
ESMO Open
|
May 13, 2021
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort
G Fornarini, S E Rebuzzi, G L Banna, et al.
ESMO Open
|
February 2, 2023
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey
M Reni, E Giommoni, F Bergamo, et al.
ESMO Open
|
October 25, 2025
COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinib
N Peled, A Tufman, L V Sequist, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 10, 2024
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey
M Reni, E Giommoni, F Bergamo, et al.
British Journal of Cancer
|
April 10, 2014
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
L Fornaro, S Cereda, G Aprile, et al.
ESMO Open
|
August 15, 2021
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey
G Orsi, M Di Marco, A Cavaliere, et al.
ESMO Open
|
January 5, 2021
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort
U Peretti, A Cavaliere, M Niger, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 130) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 130 results.
ESMO Open
|
December 24, 2021
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities
M Simbolo, G Centonze, G Ali, et al.
Journal of Viral Hepatitis
|
August 9, 2017
A different perspective on sofosbuvir-ledipasvir treatment of patients with HCV genotype 1b cirrhosis: The ital-c network study
M Barone, A Iannone, E Shahini, et al.
ESMO Open
|
January 4, 2025
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI)
M Reni, M Milella, F Bergamo, et al.
ESMO Open
|
May 13, 2021
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort
G Fornarini, S E Rebuzzi, G L Banna, et al.
ESMO Open
|
February 2, 2023
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey
M Reni, E Giommoni, F Bergamo, et al.
ESMO Open
|
October 25, 2025
COMPEL: osimertinib plus platinum-based chemotherapy in patients with EGFR-mutated advanced NSCLC and progression on first-line osimertinib
N Peled, A Tufman, L V Sequist, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
October 10, 2024
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey
M Reni, E Giommoni, F Bergamo, et al.
British Journal of Cancer
|
April 10, 2014
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
L Fornaro, S Cereda, G Aprile, et al.
ESMO Open
|
August 15, 2021
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey
G Orsi, M Di Marco, A Cavaliere, et al.
ESMO Open
|
January 5, 2021
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort
U Peretti, A Cavaliere, M Niger, et al.
Page
of 13